Current ad hoc announcements
| News reports | Ad-Hoc | General & Press | Sale of the subsidiary apoplex medical for around EUR 16.5 million
Geratal, September 18, 2024. The realignment of Geratherm Medical AG has begun. Geratherm Medical AG sells 100% of its 60.55% stake in apoplex medical technologies together with the other shareholders…
Read more
| Ad-Hoc | General & Press | Extends his contract as a member of the Management Board ahead of schedule
Geratal, February 7, 2024. The Supervisory Board and Management Board have extended the current Management Board contract by a further 3 years until December 31, 2027 in order to continue to ensure…
Read more
| Ad-Hoc | General & Press | Update: BUY recommendation with an unchanged price target of EUR 11.30
The update of the AlsterResearch study on the Geratherm Group published on August 28, 2023 continues to give a buy recommendation with an unchanged price target of EUR 11.30. Despite sluggish sales in…
Read more
| Ad-Hoc | General & Press | Update: AlsterResearch confirms buy recommendation from Geratherm
The update of the AlsterResearch study on the Geratherm Group, published on June 29, 2023, once again confirms the price target of EUR 11.30 with a clear buy recommendation. The reasons for this are…
Read more
| Ad-Hoc | Share buyback program 2023 of up to 100,000 shares
Geratal, January 17, 2023. At the last meeting of the Supervisory Board, the Supervisory Board and the Management Board of Geratherm Medical AG resolved to use the authorization granted by the…
Read more
| Ad-Hoc | General & Press | Price target of €11.30 constant
In the update to the study on the Geratherm Group published today by AlsterResearch, the upside target of EUR 11.30 can be maintained, despite the rise in energy prices and personnel costs.
Via…
Read more
| Ad-Hoc | General & Press | UPDATE AlsterResearch: Target price raised to €11.30
The study on the Geratherm Group published by AlsterResearch on July 21, 2022 and the determined price target of EUR 11.00 have now been raised to EUR 11.30 following an update on 09/21/2022. The main…
Read more
| Ad-Hoc | General & Press | Research study of Geratherm Medical by AlsterResearch
Geratal, 07/21/2022. Entitled “A fresh start in a new segment – Initiate with BUY” AlsterResearch published their study about the Geratherm Group today. Geratherm Medical is assessed by…
Read more
| Ad-Hoc | Voluntary delisting offer by JotWe GmbH published
Geratal, May 11, 2022. Today JotWe GmbH, based in Steinbach am Wald, has today published an offer document for the voluntary public takeover bid for all shares in Geratherm Medical AG, Geratal (ISIN:…
Read more
| Ad-Hoc | Capital Increase against cash contributions from authorized
Geratal, 13. April 2022. The Management Board of Geratherm Medical AG, Geratal (ISIN: DE0005495626) today resolved, with the approval of the Supervisory Board, to increase the Company's issued share…
Read more